Highly attenuated cytomegalovirus vaccine and production thereof
US3959466A · kind A · utility
18Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 15, 1974 |
| Grant date | May 25, 1976 |
| Priority date | — |
| Expiry date | Apr 15, 1994 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cytomegalovirus (CMV) vaccine, capable of inducing immunity in humans against cytomegalic inclusion disease (CID), without spread to contacts and with minimal excretion of the virus, is prepared by serially passaging virulent CMV in human diploid lung fibroblasts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.